The revival of Phage Therapy to fight Antimicrobial Resistance – Part I: What are the legal implications?

CIIR - Centre for Information and Innovation Law

1 results
- Date(ascending)

Locus licenses CRISPR tech to Janssen in potential $818m deal
Minssen, T.
09/01/2019
1 Media contribution
Press/Media: Press / Media